TGFB1 and cancer: Moreover, TGF-β is involved in the upregulation of FoxP3 in CD4+ naïve T cells, inducing their differentiation toward Tregs [82,83,84,85], and, accordingly, TGF-β blockade results in Treg depletion in different cancers [86,87].